Found 21 matching trials
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer PHASE2 This is a phase II clinical study evaluating the safety, tolerability, phar...
Show More Location
SunYat-sen University Cancer Center
Learn More & Join Trial
Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer PHASE1 This is a single-arm, open-label, Phase Ib/II clinical trial designed to ev...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma PHASE2 This is a Phase II clinical study aimed at evaluating the safety, tolerabil...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN) PHASE2 A multicenter, single-arm, open-label study evaluating the safety and effic...
Show More Location
Sun Yat-Sen University Cancer Center
Learn More & Join Trial
Phase 3 Clinical Study of AK112 for NSCLC Patients PHASE3 A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases PHASE1 An open-label, multicenter, phase Ib/II study of AK112 in combination with ...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine,No. 79, Qingchun Road, Shangcheng District, Hangzhou City, Zhejiang Province
Learn More & Join Trial
Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis PHASE1 Leptomeningeal metastasis, characterized by tumor cells infiltrating and pr...
Show More Location
The Affiliated Huizhou Hospital, Guangzhou Medical University
Learn More & Join Trial
A Study of AK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian Cancer PHASE1 Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Show More Location
Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
OVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS) PHASE2 The efficacy of OVV-01 injection in combination with AK112 injection in sub...
Show More Location
Multiple Locations
Learn More & Join Trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer PHASE2 The purpose of this study is to further advance the ability to practice per...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial